This study will determine if a monthly intravenous immunoglobulin administration, compared to intravenous placebo, will significantly reduce the rate of serious, life-threatening bacterial infections in HIV-infected children, if it will reduce the rate of viral, opportunistic and minor infections, days of hospitalization, days of antibiotic use and progression of HIV disease.
Showing the most recent 10 out of 470 publications